saccharin has been researched along with Parkinsonian Disorders in 2 studies
Saccharin: Flavoring agent and non-nutritive sweetener.
saccharin : A 1,2-benzisothiazole having a keto-group at the 3-position and two oxo substituents at the 1-position. It is used as an artificial sweetening agent.
Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Quik, M | 1 |
Campos, C | 1 |
Grady, SR | 1 |
Paumier, KL | 1 |
Sortwell, CE | 1 |
Madhavan, L | 1 |
Terpstra, B | 1 |
Celano, SL | 1 |
Green, JJ | 1 |
Imus, NM | 1 |
Marckini, N | 1 |
Daley, B | 1 |
Steece-Collier, K | 1 |
Collier, TJ | 1 |
2 other studies available for saccharin and Parkinsonian Disorders
Article | Year |
---|---|
Multiple CNS nicotinic receptors mediate L-dopa-induced dyskinesias: studies with parkinsonian nicotinic receptor knockout mice.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Central Nervous System; Cotinine; Dopamine; Dyskin | 2013 |
Chronic amitriptyline treatment attenuates nigrostriatal degeneration and significantly alters trophic support in a rat model of parkinsonism.
Topics: Adrenergic Agents; Amitriptyline; Analgesics, Non-Narcotic; Animals; Brain-Derived Neurotrophic Fact | 2015 |